Paper36175603
Clinical relevance and therapeutic aspects of professional antigen-presenting cells in lung cancer.
Shanmugam G and 4 others. Med Oncol, 2022. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Clinical relevance and therapeutic aspects of professional antigen-presenting cells in lung cancer. Papers, record 36175603. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36175603
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical relevance and therapeutic aspects of professional antigen-presenting cells in lung cancer.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigen-Presenting Cells | Major topic |
| Lung Neoplasms | Major topic |
| Antigen Presentation | |
| Humans | |
| Immunotherapy | |
| Tumor-Associated Macrophages |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| ECR/2016/000965 | Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Govt. of India | PubMed |
Source PubMed
References93
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18281925 | Lung and splenic B cells facilitate diverse effects on in vitro measures of antitumor immune responses. | Cancer Immun | 2008 | https://conductscience.org/library/papers/18281925 | PubMed |
| 2 | 25698555 | Dendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer. | Int Immunopharmacol | 2015 | https://conductscience.org/library/papers/25698555 | PubMed |
| 3 | 22086517 | M2-polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma. | Clinics (Sao Paulo) | 2011 | https://conductscience.org/library/papers/22086517 | PubMed |
| 4 | 15976491 | TLR signalling and the function of dendritic cells. | Chem Immunol Allergy | 2005 | https://conductscience.org/library/papers/15976491 | PubMed |
| 5 | 18799141 | Mechanisms and consequences of dendritic cell migration. | Immunity | 2008 | https://conductscience.org/library/papers/18799141 | PubMed |
| 6 | 12576442 | Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. | Clin Cancer Res | 2003 | https://conductscience.org/library/papers/12576442 | PubMed |
| 7 | 16467102 | Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16467102 | PubMed |
| 8 | 11923611 | Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells. | Ann Surg | 2002 | https://conductscience.org/library/papers/11923611 | PubMed |
| 9 | 30444051 | Advances in evidence-based medicine for immunotherapy of non-small cell lung cancer. | J Evid Based Med | 2018 | https://conductscience.org/library/papers/30444051 | PubMed |
| 10 | 21681372 | Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer. | Cancer Immunol Immunother | 2011 | https://conductscience.org/library/papers/21681372 | PubMed |
| 11 | 26787825 | Comprehensive Immune Profiling of Lung Adenocarcinomas Reveals Four Immunosubtypes with Plasma Cell Subtype a Negative Indicator. | Cancer Immunol Res | 2016 | https://conductscience.org/library/papers/26787825 | PubMed |
| 12 | 28848053 | Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non-Small Cell Lung Cancer Patients. | Cancer Immunol Res | 2017 | https://conductscience.org/library/papers/28848053 | PubMed |
| 13 | 11904734 | Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen. | Cancer Immunol Immunother | 2002 | https://conductscience.org/library/papers/11904734 | PubMed |
| 14 | 20420527 | INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect. | Expert Opin Biol Ther | 2010 | https://conductscience.org/library/papers/20420527 | PubMed |
| 15 | 20429924 | Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer. | BMC Cancer | 2010 | https://conductscience.org/library/papers/20429924 | PubMed |
| 16 | 24043896 | Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cells. | J Immunol | 2013 | https://conductscience.org/library/papers/24043896 | PubMed |
| 17 | 24070386 | Diversity of pathogen sensors in dendritic cells. | Adv Immunol | 2013 | https://conductscience.org/library/papers/24070386 | PubMed |
| 18 | 28129580 | Immunotherapy with Dendritic Cells Modified with Tumor-Associated Antigen Gene Demonstrates Enhanced Antitumor Effect Against Lung Cancer. | Transl Oncol | 2017 | https://conductscience.org/library/papers/28129580 | PubMed |
| 19 | 27097970 | Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer. | Radiat Oncol | 2016 | https://conductscience.org/library/papers/27097970 | PubMed |
| 20 | 15771572 | IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. | Annu Rev Immunol | 2005 | https://conductscience.org/library/papers/15771572 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42724375 | Midkine restrains T-cell mediated anti-tumor immunity by suppressing macrophage M1 polarization in lung adenocarcinoma. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42724375 | PubMed |
| 41372758 | CYP27A1 suppresses brain metastasis via ferroptosis in lung adenocarcinoma: a six-gene signature predicting the immunotherapy response and clinical outcomes. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/41372758 | PubMed |
| 40700281 | The Impact of Age on the Effectiveness of Immune Checkpoint Inhibitors Therapy in Patients with Metastatic Non-Small-Cell Lung Cancer. | Geriatrics (Basel) | 2025 | https://conductscience.org/library/papers/40700281 | PubMed |
| 39492834 | Immunometabolism: signaling pathways, homeostasis, and therapeutic targets. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/39492834 | PubMed |
| 37189748 | Autoimmunity and Carcinogenesis: Their Relationship under the Umbrella of Autophagy. | Biomedicines | 2023 | https://conductscience.org/library/papers/37189748 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36175603
GET https://conductscience.org/api/papers/v1/36175603/references?page=2